Stephen J Schuster

32PUBLICATIONS
286CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 24, 2026
Late cytopenia after CD19 chimeric antigen receptor T cell in large B cell lymphoma: A Cell Therapy Consortium Analysis.

|May 16, 2026
Investigating Associations Between Psychological Distress and Changes in Peripheral Blood Monocytes in Patients With CLL/SLL Managed With Active Surveillance.

|Feb 05, 2026
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter transformation.

Katharine Louise Lewis, Sarit E Assouline, Ross Ian Baker

|Feb 04, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells.

Ivan J Cohen, Audrey C Bochi-Layec, Jean Lemoine

|Jan 07, 2026
Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma.

Gloria Iacoboni, Emil Ramsø Kyvsgaard, Víctor Navarro Garcés

|Jan 06, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies.

Alberto Carturan, Mathew G Angelos, Puneeth Guruprasad

Pageof 6

Frequent Collaborators

11 joint publications

Marco Ruella

10 joint publications

Elise A Chong

6 joint publications

Joseph P McGurik

5 joint publications

Raymone Pajarillo